The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
about
Systemic administration of local anesthetic agents to relieve neuropathic painChronic complications of spinal cord injuryEarly acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionalsComparison between pharmacologic evaluation and repetitive transcranial magnetic stimulation-induced analgesia in poststroke pain patients.Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.A proposed algorithm for the management of pain following spinal cord injury.Chronic administration of ketamine for analgesia.Central pain syndrome: elucidation of genesis and treatment.Management of neuropathic pain following spinal cord injury: now and in the future.Lidocaine Infusion: A Promising Therapeutic Approach for Chronic PainA systematic review of pharmacologic treatments of pain after spinal cord injury.Ketamine for the treatment of chronic non-cancer pain.Combination drug therapy for chronic pain: a call for more clinical studies.Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocksManagement of Neuropathic Pain Associated with Spinal Cord Injury.Central Neuropathic Pain in Spinal Cord Injury.Spinal cord injury-induced pain: mechanisms and treatments.Importance of Pharmacological Evaluation in the Treatment of Poststroke Pain by Spinal Cord Stimulation.Intravenous lidocaine for neuropathic pain: a retrospective analysis of tolerability and efficacy.Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain.Ketamine, an NMDA-antagonist, increases the oscillatory frequencies of alpha-peaks on the electroencephalographic power spectrum.[Pain in patients with paraplegia].Relationship between bodily illusions and pain syndromes.Ketamine: miracle drug or latest fad?Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data.The analgesic effect of intravenous methylprednisolone on acute neuropathic pain with allodynia due to central cord syndrome: a retrospective study.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Ketamine infusion therapy for chronic pain management in South Korea: A national survey for pain physicians with a narrative review
P2860
Q24245505-2616ABDA-F488-4C7B-8FFE-33F08B1819D4Q27021713-E87D9498-59AE-4BFA-97C7-ACC17D96DBCAQ30440562-012FEB89-1BF5-4E73-A642-8B4222DDD8FDQ34322109-730426F9-A208-487E-9DAC-6F1415F19AD0Q35871129-B1C0582C-4A1E-45DC-B20A-1A86A563EFF7Q35923194-FD723981-2241-4C68-83B6-062911E064CEQ35972237-E885C38A-BF4F-4128-8076-C11EE8B966B4Q36238133-AC4CB152-4771-41D6-966F-FDE97056D6E8Q36790314-7B061F7B-AFE3-4D9D-8884-24DDD29703DFQ36998830-EB224D2A-54C8-4A79-8CD0-166429ACDD63Q37323333-6007336D-8F42-45B4-9CA4-A7027CF7C765Q37662423-EFD934FA-3686-420D-90E8-B9FBB2765727Q37740479-6FB416D2-418D-4332-8249-D0505269AE7BQ37786623-BA1BE1F2-6B5F-4415-A1D8-5BEE679F1E3EQ37790054-CDDA5EC4-ADFE-4220-B4B9-55EFE7918BDAQ38011182-44E65562-2B5A-49CC-98F8-FBE7C90415F2Q38368276-718BACC8-DFF9-4DE6-AB6C-2199AD407097Q38422471-1C43BE3F-0C07-4525-BF51-085D9EF0003DQ38592156-F6CA6369-54C1-4CBF-91E3-0BDA1939ED2CQ39175143-15FD99D7-24FB-4D10-BB9A-7F3F8116159EQ41661250-15417008-1341-446A-AFF0-6225CC5BB384Q41835834-6C572109-DCE4-45ED-9AAF-E4D722248D5CQ48612469-07E39284-A6BA-42AF-837D-C0C74FF621F3Q49906971-6BE9C3D0-588A-469D-8502-DDBC33B353AFQ50804274-ACCED71F-2C97-4E4A-9796-14ADFF6158D6Q52553682-DD35B2C6-8ADA-43E6-BDB1-58B55D7A1F48Q54960127-868A8206-49CC-440C-963D-E4ED6AEC86CEQ55427168-A99F3CD9-4BAA-4000-ACDE-26CE0D6EC8C6Q55535831-DBA8DC44-C6DC-49D7-B475-600D4097961FQ57211059-F93CFEF3-150C-4E97-A4E6-5C01DA93BE9F
P2860
The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The analgesic effect of intrav ...... pain after spinal cord injury.
@en
The analgesic effect of intrav ...... pain after spinal cord injury.
@nl
type
label
The analgesic effect of intrav ...... pain after spinal cord injury.
@en
The analgesic effect of intrav ...... pain after spinal cord injury.
@nl
prefLabel
The analgesic effect of intrav ...... pain after spinal cord injury.
@en
The analgesic effect of intrav ...... pain after spinal cord injury.
@nl
P2093
P2860
P1476
The analgesic effect of intrav ...... pain after spinal cord injury.
@en
P2093
Karlsten R
Kvarnström A
P2860
P304
P356
10.1111/J.1399-6576.2003.00330.X
P407
P577
2004-04-01T00:00:00Z